Phosphodiesterase type 5 inhibitor therapy provides sustained relief of symptoms among patients with chronic pelvic pain syndrome

BACKGROUND: Chronic prostatitis/chronic pelvic pain syndrome type III (CP/CPPS) is associated with pelvic pain, sexual dysfunction and irritative voiding. Sustained symptom relief has proven difficult with alpha blockers, antibiotics, and nonsteroidal anti-inflammatory drugs (NSAIDs). Phosphodiester...

Descripción completa

Detalles Bibliográficos
Autores principales: Pineault, Kevin, Ray, Shagnik, Gabrielson, Andrew, Herati, Amin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214994/
https://www.ncbi.nlm.nih.gov/pubmed/32420144
http://dx.doi.org/10.21037/tau.2020.03.05

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214994/
https://www.ncbi.nlm.nih.gov/pubmed/32420144
http://dx.doi.org/10.21037/tau.2020.03.05

Ejemplares similares